Cargando…
Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography
BACKGROUND: Little data exist on real-world patterns and associated costs of downstream breast diagnostic procedures following an abnormal screening mammography or clinical exam. OBJECTIVES: To analyze the utilization patterns in real-world clinical settings for breast imaging and diagnostic procedu...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875586/ https://www.ncbi.nlm.nih.gov/pubmed/29618934 http://dx.doi.org/10.2147/CEOR.S150260 |
_version_ | 1783310375652950016 |
---|---|
author | Vlahiotis, Anna Griffin, Brian Stavros, A Thomas Margolis, Jay |
author_facet | Vlahiotis, Anna Griffin, Brian Stavros, A Thomas Margolis, Jay |
author_sort | Vlahiotis, Anna |
collection | PubMed |
description | BACKGROUND: Little data exist on real-world patterns and associated costs of downstream breast diagnostic procedures following an abnormal screening mammography or clinical exam. OBJECTIVES: To analyze the utilization patterns in real-world clinical settings for breast imaging and diagnostic procedures, including the frequency and volume of patients and procedures, procedure sequencing, and associated health care expenditures. MATERIALS AND METHODS: Using medical claims from 2011 to 2015 MarketScan Commercial and Medicare Databases, adult females with breast imaging/diagnostic procedures (diagnostic mammography, ultrasound, molecular breast imaging, tomosynthesis, magnetic resonance imaging, or biopsy) other than screening mammography were selected. Continuous health plan coverage without breast diagnostic procedures was required for ≥13 months before the first found breast diagnostic procedure (index event), with a 13-month post-index follow-up period. Key outcomes included diagnostic procedure volumes, sequences, and payments. Results reported descriptively were projected to provide US national patient and procedure volumes. RESULTS: The final sample of 875,526 patients was nationally projected to 12,394,432 patients annually receiving 8,732,909 diagnostic mammograms (53.3% of patients), 6,987,399 breast ultrasounds (42.4% of patients), and 1,585,856 biopsies (10.3% of patients). Following initial diagnostic procedures, 49.4% had second procedures, 20.1% followed with third procedures, and 10.0% had a fourth procedure. Mean (SD) costs for diagnostic mammograms of US$349 ($493), ultrasounds US$132 ($134), and biopsies US$1,938 ($2,343) contributed US$3.05 billion, US$0.92 billion, and US$3.07 billion, respectively, to annual diagnostic breast expenditures estimated at US$7.91 billion. CONCLUSION: The volume and expense of additional breast diagnostic testing, estimated at US$7.91 billion annually, underscores the need for technological improvements in the breast diagnostic landscape. |
format | Online Article Text |
id | pubmed-5875586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58755862018-04-04 Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography Vlahiotis, Anna Griffin, Brian Stavros, A Thomas Margolis, Jay Clinicoecon Outcomes Res Original Research BACKGROUND: Little data exist on real-world patterns and associated costs of downstream breast diagnostic procedures following an abnormal screening mammography or clinical exam. OBJECTIVES: To analyze the utilization patterns in real-world clinical settings for breast imaging and diagnostic procedures, including the frequency and volume of patients and procedures, procedure sequencing, and associated health care expenditures. MATERIALS AND METHODS: Using medical claims from 2011 to 2015 MarketScan Commercial and Medicare Databases, adult females with breast imaging/diagnostic procedures (diagnostic mammography, ultrasound, molecular breast imaging, tomosynthesis, magnetic resonance imaging, or biopsy) other than screening mammography were selected. Continuous health plan coverage without breast diagnostic procedures was required for ≥13 months before the first found breast diagnostic procedure (index event), with a 13-month post-index follow-up period. Key outcomes included diagnostic procedure volumes, sequences, and payments. Results reported descriptively were projected to provide US national patient and procedure volumes. RESULTS: The final sample of 875,526 patients was nationally projected to 12,394,432 patients annually receiving 8,732,909 diagnostic mammograms (53.3% of patients), 6,987,399 breast ultrasounds (42.4% of patients), and 1,585,856 biopsies (10.3% of patients). Following initial diagnostic procedures, 49.4% had second procedures, 20.1% followed with third procedures, and 10.0% had a fourth procedure. Mean (SD) costs for diagnostic mammograms of US$349 ($493), ultrasounds US$132 ($134), and biopsies US$1,938 ($2,343) contributed US$3.05 billion, US$0.92 billion, and US$3.07 billion, respectively, to annual diagnostic breast expenditures estimated at US$7.91 billion. CONCLUSION: The volume and expense of additional breast diagnostic testing, estimated at US$7.91 billion annually, underscores the need for technological improvements in the breast diagnostic landscape. Dove Medical Press 2018-03-26 /pmc/articles/PMC5875586/ /pubmed/29618934 http://dx.doi.org/10.2147/CEOR.S150260 Text en © 2018 Vlahiotis et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Vlahiotis, Anna Griffin, Brian Stavros, A Thomas Margolis, Jay Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography |
title | Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography |
title_full | Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography |
title_fullStr | Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography |
title_full_unstemmed | Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography |
title_short | Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography |
title_sort | analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875586/ https://www.ncbi.nlm.nih.gov/pubmed/29618934 http://dx.doi.org/10.2147/CEOR.S150260 |
work_keys_str_mv | AT vlahiotisanna analysisofutilizationpatternsandassociatedcostsofthebreastimaginganddiagnosticproceduresafterscreeningmammography AT griffinbrian analysisofutilizationpatternsandassociatedcostsofthebreastimaginganddiagnosticproceduresafterscreeningmammography AT stavrosathomas analysisofutilizationpatternsandassociatedcostsofthebreastimaginganddiagnosticproceduresafterscreeningmammography AT margolisjay analysisofutilizationpatternsandassociatedcostsofthebreastimaginganddiagnosticproceduresafterscreeningmammography |